[
    {
        "primary_outcome": "the rate of acute gastrointestinal complications",
        "reported_outcome": "the risk of acute gastrointestinal complications",
        "label": 1
    },
    {
        "primary_outcome": "more frequently interrupted MARS sessions without anticoagulation",
        "reported_outcome": "had to be terminated prematurely",
        "label": 1
    },
    {
        "primary_outcome": "the prevalence of arm, shoulder and neck symptoms",
        "reported_outcome": "symptoms",
        "label": 1
    },
    {
        "primary_outcome": "trough FEV 1 after 12 weeks of treatment",
        "reported_outcome": "trough FEV 1 after one dose",
        "label": 1
    },
    {
        "primary_outcome": "pain catastrophising",
        "reported_outcome": "global PC",
        "label": 1
    },
    {
        "primary_outcome": "morning peak expiratory flow after 4 weeks treatment",
        "reported_outcome": "asthma quality of life score",
        "label": 0
    },
    {
        "primary_outcome": "changes in disc height as measured on CT scans",
        "reported_outcome": "pain",
        "label": 0
    },
    {
        "primary_outcome": "blood pressure",
        "reported_outcome": "the compliance in all the control criteria, except for LDL cholesterol",
        "label": 0
    },
    {
        "primary_outcome": "incidence of low back pain resulting in the seeking of health care",
        "reported_outcome": "low back pain episodes",
        "label": 0
    },
    {
        "primary_outcome": "patient intention to visit a psychosocial counselor",
        "reported_outcome": "patient satisfaction",
        "label": 0
    }
]
